Precision oncology demands precision
Introducing Illumina informatics for oncology. Powered by DRAGEN™, winner of the PrecisionFDA Truth Challenge, and Illumina Connected Insights for somatic oncology variant interpretation.
Illumina informatics is precision-engineered to enhance accuracy of results and accelerate reporting for any assay, at any scale.
Sample to answer workflows packaged within an elegantly designed interface, all supported by your trusted partner in precision medicine.
Unlock meaning for a wide range of clinical research applications
Solid tumor
Liquid biopsy
Heme
Methylation
Expression
MRD and monitoring
Targeted panels | CGP | WTS , WES, WGS
SNV, MNV, CNV, SV, Fusions, Indels, Splice variants, LOH, HLA, TMB, MSI, GIS, Tumor Purity, Ploidy, mutational signatures
Sophisticated interface
See Illumina Connected Insights in action.
Automated oncogenicity prediction
Powerful visualizations
Customizable filtering
Benefits of Illumina software
User-friendly for faster adoption
DRAGEN secondary analysis and Connected Insights make NGS accessible for any lab, offering intuitive interfaces, flexible deployment options and self-serve workflows.
Optimized for operational efficiency
World-record speeds of DRAGEN3-4 and seamless integration with Connected Insights enable no-touch workflows, simplified implementation, and rapid turnaround times.
Powered for growth
From targeted panels to WGS, Illumina informatics support a wide range of oncology applications and sample volumes.
Streamlined reporting
Designed to work together, Illumina informatics reduce manual touchpoints and time to report.
One secure environment
Storage in a single, secure cloud minimizes data duplication and transfers.
AI-backed insights
Variant calling, oncogenicity prediction, and variant curation backed by proprietary Illumina AI algorithms help labs analyze and interpret data with confidence.
A unified sample to report experience
Prep
Illumina or third-party provider
- Pillar oncoReveal® Myeloid
- Illumina DNA Prep
- Illumina DNA Prep with Enrichment
Resources
WEBINAR
The future of precision oncology: scaling NGS with smarter variant interpretation
The landscape for precision oncology has witnessed a remarkable trajectory in recent decades with the adoption of next-generation sequencing tests like comprehensive genomic profiling driving research into the genomic drivers of cancer. Hospital Son Espases is deriving critical oncology insights for the 1.2 million people in its service area, leveraging the Illumina informatics portfolio. Dr. Obrador offers a strategic roadmap for laboratories eager to embrace the transformative potential of genomics in precision oncology
Antonia Obrador, PHD
Oncology Area Coordinator
Genetics and Genomics Unit of Balearic Islands
Son Espases University Hospital
Jing Gao, PhD
Vice President and Global Head of Clinical Informatics
Illumina
Brochure
Key considerations and best practices for implementing a streamlined tertiary analysis workflow.
NewsCenter Story
Territory Pathology expands into cancer genomics, adopting an end-to-end Illumina informatics workflow for hematological and solid tumor-based cancers
eBook
Tertiary analysis software can help address the bottleneck for somatic oncology variant interpretation.
Podcast
Jing Gao, VP of Illumina Informatics, speaks to Illumina’s vision for oncology informatics